Get the Stockscreener App
88.27
1.23%
-1.10
Iradimed Corp stock is traded at $88.27, with a volume of 78,800.
It is down -1.23% in the last 24 hours and up +6.89% over the past month.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
See More
Previous Close:
$89.37
Open:
$89.53
24h Volume:
78,800
Relative Volume:
0.79
Market Cap:
$1.13B
Revenue:
$86.28M
Net Income/Loss:
$23.61M
P/E Ratio:
48.08
EPS:
1.8359
Net Cash Flow:
$23.97M
1W Performance:
+0.94%
1M Performance:
+6.89%
6M Performance:
-3.93%
1Y Performance:
+16.07%
1-Day Range:
$88.09
$90.43
1-Week Range:
$86.86
$91.05
52-Week Range:
$73.02
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
88.27 | 1.13B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-22-26 | Initiated | Needham | Hold |
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
(IRMD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
iRadimed (IRMD) Rises 1.83% to $87.45, Sitting Midway Between Support and ResistanceCovered Call ETF - https://www.siam.in/
(IRMD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
IRadimed Director Joe Kiani Acquires 698 Shares Through RSU Vesting on September 23, 2026 - Kalkine Media
698 stock units became shares for IRADIMED (NASDAQ: IRMD) director Joe E. Kiani. - Stock Titan
Form 4 Iradimed Co For: 25 September By Investing.com - Investing.com UK
One-on-one investor meetings with Iradimed's CFO are set for New York - Stock Titan
IRADIMED Insiders Sell US$3.4m Of Stock, Possibly Signalling Caution - Moomoo
Needham initiates IRadimed stock with Hold on valuation concerns By Investing.com - Investing.com Australia
Needham Initiates IRadimed at Hold - marketscreener.com
Needham initiates IRadimed stock with Hold on valuation concerns - Investing.com
(IRMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Iradimed Stock Price Forecast. Should You Buy IRMD? - StockInvest.us
iRadimed Corporation (IRMD) Stock Analysis: Exploring a 42% Upside Potential for Investors - DirectorsTalk Interviews
Is IRADIMED (IRMD) Overvalued After A 157% Five Year Run? - webull.com
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com Australia
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com Nigeria
Iradimed director Monty Allen sells $122,621 in stock - Investing.com
Iradimed director Monty Allen sells $122,621 in stock - Investing.com India
Iradimed director Monty Allen sells $122,621 in stock - Investing.com
Director at IRADIMED (IRMD) sells 1,419 shares - stocktitan.net
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com South Africa
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100 - GuruFocus
IRADIMED (NASDAQ: IRMD) director flags 1,102 RSU shares for possible sale - stocktitan.net
Price to book forward of IRadimed Corp. – TRADEGATE:46K - TradingView
Rice Hall James & Associates LLC Invests $2.91 Million in iRadimed Corporation $IRMD - MarketBeat
Form 8K Iradimed Co For: 18 August By Investing.com - Investing.com UK
iRadimed (NASDAQ:IRMD) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat
IRMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
IRadimed (IRMD) Q2 2026 Earnings Call Transcript - webull.com
IRADIMED CORPORATION (NASDAQ:IRMD) Looks Interesting, And It's About To Pay A Dividend - Simply Wall Street
iRadimed (NASDAQ:IRMD) Cut to "Hold" at Wall Street Zen - MarketBeat
IRadimed (IRMD) Q2 2026 Earnings Call Transcript - AOL.com
How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors - Yahoo Finance
Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth - Yahoo Finance
iRadimed Q2 2026 Earnings: EPS Beat Highlights Resilience in MRI-Safe Medical Device NicheEarnings Call Transcript - careplusvn.com
Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD) - simplywall.st
iRadimed (IRMD) Eases 0.74% as Shares Hold Within Established Trading RangeWyckoff Spring - careplusvn.com
IRadimed Corp Earnings Call Highlights Ramp, Resilience - TipRanks
iRadimed (IRMD) Gains 1.71% as Shares Hold Above SupportTriple Bottom - dars.gov.et
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ... By GuruFocus - Investing.com Canada
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ... - Yahoo Finance
IRADIMED (IRMD) Stock Drops As 3870 Ramp Cuts Gross Margin - Sahm
IRadimed Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
IRadimed Corp reports results for the quarter ended June 30Earnings Summary - tradingview.com
Earnings call transcript: IRadimed tops Q2 2026 estimates as 3870 ramp weighs margins - Investing.com
IRADIMED ($IRMD) Releases Q2 2026 Earnings - Quiver Quantitative
IRadimed: Q2 Earnings Snapshot - kare11.com
IRADIMED: More Than 70% of New Pump Orders Were Four-Pump Setups - Stock Titan
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Iradimed Corp Stock (IRMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Monty K. Allen | Director |
Sep 03 '26 |
Proposed Sale |
86.42 |
1,419 |
122,624 |
0 |
| Scharen-Guivel Hilda Frederiqu | Director |
Jun 04 '26 |
Sale |
95.00 |
3,000 |
285,000 |
5,598 |
| Hilda Scharen-Guivel | Director |
Jun 04 '26 |
Proposed Sale |
95.00 |
3,000 |
285,000 |
0 |
| Susi Roger E. | CEO, President, Chairman |
Jun 01 '26 |
Sale |
90.60 |
2,500 |
226,507 |
2,162,500 |
| Susi Roger E. | CEO, President, Chairman |
May 27 '26 |
Sale |
91.95 |
2,500 |
229,878 |
2,165,000 |
| Susi Roger E. | CEO, President, Chairman |
May 26 '26 |
Sale |
92.23 |
5,000 |
461,166 |
2,167,500 |
| Susi Roger E. | CEO, President, Chairman |
May 19 '26 |
Sale |
87.88 |
2,500 |
219,694 |
2,172,500 |
| Susi Roger E. | CEO, President, Chairman |
May 18 '26 |
Sale |
87.51 |
5,000 |
437,571 |
2,175,000 |
| Susi Roger E. | CEO, President, Chairman |
May 12 '26 |
Sale |
83.92 |
4,411 |
370,183 |
2,180,000 |
| Susi Roger E. | CEO, President, Chairman |
May 11 '26 |
Sale |
84.54 |
3,089 |
261,157 |
2,184,411 |
1.69%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):